The synthetic cannabinoid and CB1/CB2 agonist WIN55212,2 decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating TRPV1 and non-cannabinoid receptor targets

Lowin, Torsten and Graeber, Angelika and Straub, Rainer H. (2013) The synthetic cannabinoid and CB1/CB2 agonist WIN55212,2 decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating TRPV1 and non-cannabinoid receptor targets. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 31 (5). p. 833. ISSN 0392-856X, 1593-098X

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin I
Depositing User: Petra Gürster
Date Deposited: 18 Jun 2020 08:47
Last Modified: 18 Jun 2020 08:47
URI: https://pred.uni-regensburg.de/id/eprint/16102

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.